Cell populations which co-express CD49c and CD90
Abstract
Substantially homogenous cells populations which co-express CD49c, CD90 and telomerase are made. In one embodiment, humans suffering from a degenerative, traumatic, acute injury, cardiac or neurological condition are treated with the substantially homogenous cells populations which co-express CD49c, CD90 and telomerase. In another embodiment, committed progenitor cells are made are made by selecting from a cultured source of a cell population which co-express CD49c and CD90 and modifying the cell population. The committed progenitor cells can be employed to treat a human suffering from a degenerative, traumatic, acute injury cardiac or neurological condition and formulate pharmaceutical compositions.
Claims
exact text as granted — not AI-modified1 . A substantially homogenous cell population which co-express CD49c, CD90 and telomerase.
2 - 96 . (canceled)
97 . An isolated cell population derived from human bone marrow, wherein the cells of the cell population co-express CD49c and CD90, and wherein the cells of the population can differentiate into cell types of at least two of ectodermal, endodermal, or mesodermal lineages.
98 . An isolated cell population derived from human bone marrow, wherein the cells of the cell population co-express CD49c, CD90, and telomerase.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.